The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the Bipolar CHOICE study

Well-conducted randomized trials have established or supported the efficacy of lithium, a classic mood stabilizer, and quetiapine, a commonly-prescribed atypical antipsychotic drug, for the long-term treatment of adults with bipolar I or II disorder (Vieta et  al. 2011; Geddes JR et al. 2004; Geddes and Miklowitz, 2013). However, they are also associated with increases in body weight (Dent 2012), and their effects on anthropometric measures (e.g., body weight, body mass index [BMI], and waist circumference) have seldom been directly compared beyond 8 w eeks of treatment (Bowden et al.
Source: Journal of Affective Disorders - Category: Neurology Authors: Source Type: research